MiCo BioMed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan '25 Jan 16, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	57,019	80,681	87,860	166,501	204,207	82,235
Market Cap Growth	-2.02%	-8.17%	-47.23%	-18.46%	148.32%	-
Enterprise Value	69,826	100,389	97,164	156,031	213,436	-
Last Close Price	1309.00	1852.00	3081.22	5841.47	7221.60	4326.54
PS Ratio	6.45	15.03	5.45	5.49	4.47	20.07
PB Ratio	3.62	2.22	4.98	3.19	3.65	82.20
P/TBV Ratio	8.13	2.61	5.32	3.27	3.70	332.97
EV/Sales Ratio	8.41	18.70	6.03	5.15	4.67	-
EV/EBITDA Ratio	-	-	-	-	40.72	-
EV/EBIT Ratio	-	-	-	-	61.59	-
Debt / Equity Ratio	0.88	0.38	1.32	0.42	0.12	19.03
Debt / EBITDA Ratio	-	-	-	-	1.28	-
Asset Turnover	0.20	0.09	0.22	0.38	0.95	-
Inventory Turnover	1.46	0.85	0.92	0.82	2.03	-
Quick Ratio	0.40	1.42	0.57	4.02	3.93	0.58
Current Ratio	1.38	2.70	1.33	5.94	6.46	0.91
Return on Equity (ROE)	-290.20%	-95.59%	-111.40%	-19.57%	-20.29%	-
Return on Assets (ROA)	-38.91%	-21.02%	-22.16%	-8.50%	4.51%	-
Return on Capital (ROIC)	-52.77%	-27.48%	-28.10%	-9.90%	5.24%	-
Earnings Yield	-55.99%	-31.95%	-44.27%	-6.35%	-2.83%	-17.79%
FCF Yield	-28.20%	-14.56%	-17.79%	-6.87%	-11.97%	-14.32%
Buyback Yield / Dilution	-86.40%	-12.70%	-0.19%	-25.24%	-22.97%	-
Total Shareholder Return	-86.40%	-12.70%	-0.19%	-25.24%	-22.97%	-

Source: S&P Capital IQ. Standard template. Financial Sources.